Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 87, Issue 5, Pages 537-546Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00109-009-0451-6
Keywords
Obesity; SNP; Population genetics
Funding
- French Government
- Agence Nationale de la Recherche
- Programme national de recherche sur le diabete
- CNAMTS
- Lilly
- Novartis Pharma
- Sanofi-Aventis
- INSERM
- Association Diabete Risque Vasculaire
- Federation Francaise de Cardiologie
- Fondation de France
- ALFEDIAM
- ONIVINS
- Ardix Medical
- Bayer Diagnostics
- Becton Dickinson
- Cardionics
- Merck Sant
- Novo Nordisk
- Pierre Fabre
- Roche
- Topcon
- Oulu University Hospital, Finland
- Academy of Finland
- European Commission [QLG1-CT- 2000-01643]
- MRC [G0600331] Funding Source: UKRI
- Medical Research Council [G0600331] Funding Source: researchfish
Ask authors/readers for more resources
Genome-wide association scans recently identified common polymorphisms, in intron 1 of FTO and 188 kb downstream MC4R, that modulate body mass index (BMI) and associate with increased risk of obesity. Although their individual contribution to obesity phenotype is modest, their combined effects and their interactions with environmental factors remained to be evaluated in large general populations from birth to adulthood. In the present study, we analyzed independent and combined effects of the FTO rs1421085 and MC4R rs17782313 risk alleles on BMI, fat mass, prevalence and incidence of obesity and subsequent type 2 diabetes (T2D) as well as their interactions with physical activity levels and gender in two European prospective population-based cohorts of 4,762 Finnish adolescents (NFBC 1986) and 3,167 French adults (D.E.S.I.R.). Compared to participants carrying neither FTO nor MC4R risk allele (20-24% of the populations), subjects with three or four risk alleles (7-10% of the populations) had a 3-fold increased susceptibility of developing obesity during childhood. In adults, their combined effects were more modest (similar to 1.8-fold increased risk) and associated with a 1.27% increase in fat mass (P = 0.001). Prospectively, we demonstrated that each FTO and MC4R risk allele increased obesity and T2D incidences by 24% (P = 0.02) and 21% (P = 0.02), respectively. However, the effect on T2D disappeared after adjustment for BMI. The Z-BMI and ponderal index of newborns homozygous for the rs1421085 C allele were 0.1 units (P = 0.02) and 0.27 g/cm(3) (P = 0.005) higher, respectively, than in those without FTO risk allele. The MC4R rs17782313 C allele was more associated with obesity and fat mass deposition in males than in females (P = 0.003 and P = 0.03, respectively) and low physical activity accentuated the effect of the FTO polymorphism on BMI increase and obesity prevalence (P = 0.008 and P = 0.01, respectively). In European general populations, the combined effects of common polymorphisms in FTO and MC4R are therefore additive, predictive of obesity and T2D, and may be influenced by interactions with physical activity levels and gender, respectively.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available